TP53 and colorectal carcinoma: The results indicated that treatment of the CRC cell line with 5 μmol/L, 10 μmol/L, and 20 μmol/L Juglone had significantly increased the expression of p53 protein in a dose-dependent manner compared to untreated (0 μmol/L) cells.